On May 22, 2018, the editors of The Wall Street Journal will convene influential business leaders, policy makers and experts from across the health and health-care industries to focus on the innovations transforming this critical sector of the economy.
DDF Venture Partner Barbara Tate will be participating in a session entitled 'Treating the Brain', discussing how efforts to crack the code of Alzheimer’s and develop effective therapies have met with failure after failure, but many companies and scientists are still optimistic they will find a way to treat the memory-robbing disease.
The event is being held in Washington DC, and invitations to attend can be requested from the event site below:
